Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank86
3Y CAGR+10.4%
5Y CAGR-11.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+10.4%/yr
vs +35.5%/yr prior
5Y CAGR
-11.3%/yr
Recent acceleration
Acceleration
-25.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $167.85M | +16.0% |
| 2024 | $144.76M | +76.0% |
| 2023 | $82.25M | -34.1% |
| 2022 | $124.78M | -40.3% |
| 2021 | $208.89M | -31.5% |
| 2020 | $304.96M | +83.6% |
| 2019 | $166.13M | +349.3% |
| 2018 | $36.97M | +7.3% |
| 2017 | $34.47M | -9.7% |
| 2016 | $38.16M | - |